MILFORD, Mass. — SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, announced today that the company’s precision medicine business unit has launched its second product in a growing line of reference materials for next-generation sequencing (NGS)-based tumor profiling assays. The SeraseqTM Solid Tumor Mutation Mix-I (AF1-10) contains the same mixture of […]
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced that its next generation sequencing (“NGS”) analysis and interpretation tools, VarElect(https://varelect.genecards.org), the NGS phenotyper, and GeneAnalytics™ (https://geneanalytics.genecards.org/), a novel gene set analysis tool, has been licensed by SciLifeLab (www.scilifelab.se). SciLifeLab is a Sweden-based leading provider of molecular biosciences services to leading biomedical research institutions and companies. […]
IRVINE, Calif. — Celemics, a global pioneer of personalized medicine genetics, today announced its expansion into the North American market with the establishment of Celemics America, Inc. – Expansion aims to provide increased accessibility to proprietary target enrichment technology to increase performance of Next Generation Sequencing applications. Celemics, the first Next Generation Sequencing test kit […]
LEIDEN – BIOKÉ, a Cell Signaling Technology Europe (CST Europe) company, and Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the international life science company supplying research tools and services that power genomics research and the development of personalized medicines, announced that they have signed an exclusive agreement allowing BIOKE to distribute Horizon’s […]
HILDEN, Germany & MOUNTAIN VIEW, Calif. — DNAnexus Inc., the leader in cloud-based genome informatics and data management, today announced that QIAGEN, a leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights, has integrated the DNAnexus cloud genomics platform with Ingenuity Variant Analysis, QIAGEN’s leading variant interpretation solution. […]
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) is sharing its vision for precision medicine this week at the annual meeting of the American Society of Human Genomics. The conference, held in Baltimore, Maryland, is a forum for discussing recent advances in all areas of human genetics. “As new technologies and greater understanding of […]
The human microbiome — the total collection of bacteria, viruses and other microorganisms living in and on your body — has been linked to a variety of health and disease states, including obesity, allergies, asthma, and a rapidly growing list of other conditions. But as researchers try to sort out the complex relationship between microbial […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced the launch of new TruSeq® library preparation kits and Infinium® arrays that enable researchers to explore genetic variation on a more comprehensive scale. The new additions to the application-driven portfolio address a broad range of genetic studies from whole exome to population and disease specific genotyping, leveraging […]
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today launched an enhanced portfolio of training courses to match the needs of the company’s global customers in terms of location, format and timeframe. Agilent University, a long-trusted source of traditional classroom and customized onsite training, now offers online courses that cover foundational, intermediate and advanced […]
BALTIMORE — ASHG 2015–For attendees of the 65th Annual Meeting of the American Society of Human Genetics (ASHG), Thermo Fisher Scientific is unveiling a range of innovative products and solutions that span the entire genetic analysis workflow (booth #1415). The company is also featuring several poster presentations and a lunch seminar on Wednesday, Oct. 7 […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
